Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03345472 · ClinicalTrials.gov registry record · NA

Vectors Post Market: A Study to Assess Pain Relief Using Spinal Cord Stimulation

A NA study, sponsored by MedtronicNeuro.

Completed
Registry status
NA
Development phase
175
Enrollment target

NCT03345472 is a NA study that has completed, run by MedtronicNeuro. The registered enrollment target is 175 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03345472, a NA study, has completed, sponsored by MedtronicNeuro.

COMPLETED
Registry status
NA
Development phase
175 participants
Enrollment target

Study Summary

This is a prospective, single-arm, multi-center study evaluating the efficacy of spinal cord stimulation (SCS) therapy for pain relief using high dose (HD) stimulation parameters delivered to neural targets identified during current commercial trial stimulation procedures. The study will evaluate changes in back and leg pain from baseline to 3, 6, and 12 months.

Interventions

  • DEVICE Spinal Cord Stimulation System

Trial Details

FieldValue
Enrollment Target 175 participants
Start Date 2017-11-30
Est. Completion 2019-10-21
Phase NA

Sponsor

MedtronicNeuro

51 total trials

What the Registry Record Tells You About NCT03345472

The ClinicalTrials.gov registry entry for NCT03345472 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedtronicNeuro, which has 51 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Spinal Cord Stimulation System is the first listed.

NCT03345472 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03345472 about?

NCT03345472 is a clinical study titled "Vectors Post Market: A Study to Assess Pain Relief Using Spinal Cord Stimulation". This is a prospective, single-arm, multi-center study evaluating the efficacy of spinal cord stimulation (SCS) therapy for pain relief using high dose (HD) stimulation parameters delivered to neural targets identified during current commercial trial stimulation procedures. The study will evaluate ch...

What is the current status of trial NCT03345472?

This trial is currently completed. It is a NA study. The enrollment target is 175 participants. The study started on 2017-11-30. Estimated completion is 2019-10-21.

What interventions are being tested in trial NCT03345472?

The interventions under investigation include: Spinal Cord Stimulation System (DEVICE).

Who is sponsoring clinical trial NCT03345472?

This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.